PVF_55_Rev_2_June_2020_Submission_Declaration_by_Investigators
Size: 102KB
PVF_76-Rev_1_May_2022_Annual_progress_reporting_form-MCAZ
Size: 293KB
PVF_82_Rev_0_May_2020_Application_for_a_Clinical_Trial_Protocol_Amendment
Size: 137KB
PVF_55_Rev_2_June_2020_Submission_Declaration_by_Investigators
Size: 102KB
PVF 17 Rev 0_August 2021 Medicines Safety and Monitoring Form for COVID-19 Prophylaxis
Size: 99KB
Published: February 8, 2022
PVF 16 Rev 0_August 2021 Medicines Safety and Monitoring Form for COVID-19 Treatment
Size: 104KB
Appendix I – LEF 18 Rev 3_June 2019 – RECORD OF BULK IMPORTATION OF UNREGISTERED MEDICINES
Size: 34KB
PVF 83 Rev 0_May 2020 Application For Additional Investigators Change Of Investigators Or Additional Clinical Trial Sites
Size: 92KB
Published: December 4, 2021
PVF 81 Rev 0_May 2020 Declaration By Co- And Sub-Investigators For GCP Compliance (1)
Size: 85KB
Published: December 4, 2021
PVF 80 Rev 0_May 2020 Declaration By Principal Investigator For GCP Compliance
Size: 85KB
Published: December 4, 2021
PVF 79 Rev_0 May 2020 Joint Declaration By Sponsor And Principal Investigator Concerning Sufficient Funds To Complete Study
Size: 84KB
Published: December 4, 2021
PVF 78 Rev 0_May 2020 Recommended Format For CVs Of Individuals Participating In Clinical Trials
Size: 85KB
Published: December 4, 2021
PVF 30 Rev 4_August 2020 Applicants Contact Details Update Form
Size: 129KB
Published: December 4, 2021
PVF 30 Rev 4_August 2020 Applicants Contact Details Update Form
Size: 129KB
Published: December 4, 2021
PVF 27 Rev 4_October 2020 Meeting Request Form
Size: 122KB
Published: December 4, 2021
1 2

 464 total views